Model Predicts Severe Asthma Based on Immune-Related Hub Genes
Researchers have identified immune response-related hub genes that could act as diagnostic markers and potentially therapeutic targets for severe asthma.
Read MoreFeb 12, 2025
Researchers have identified immune response-related hub genes that could act as diagnostic markers and potentially therapeutic targets for severe asthma.
Read MoreFeb 7, 2025
Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes Martin Schmid, PhD, and colleagues.
Read MoreJan 30, 2025
Chronic cough in severe asthma was associated with worsened asthma control and patient QOL, according to a recent study published in JACI: In Practice.
Read MoreJan 30, 2025
A study of US insurance data determined ABPA prevalence among patients with asthma and those with CF and offered insights into testing and treatment patterns.
Read MoreJan 10, 2025
A psychoeducational intervention for extrapulmonary manifestations of severe asthma was found feasible and rated as beneficial by patients.
Read MoreJan 9, 2025
Bronchial biopsy appears more precise than T2 score in predicting response to biological therapy for severe uncontrolled asthma.
Read MoreJan 8, 2025
Study results indicate that sputum total IgE can be used as an indicator of uncontrolled asthma.
Read MoreDec 25, 2024
Researchers gathered real-world data on biologic therapy to determine the feasibility of targeting clinical remission when treating patients with severe asthma.
Read MoreDec 24, 2024
Early improvement was linked to lower baseline FEV1 and higher eosinophils in severe eosinophilic asthma, while late improvement was linked to high ACT scores.
Read MoreDec 23, 2024
Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study.
Read More